OMNICELL, INC. — Director's Dealing 2021

Feb 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2021-02-09

Reporting Person: Kuipers Peter J. (Executive V P& CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-09	Common Stock	A	9520	—	Acquired	60363	Direct
2021-02-09	Common Stock	A	11350	—	Acquired	71713	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	50843	Direct

Footnotes

F1: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2022 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% or 150% or 200% of the numbers reflected above, depending upon the Company's performance.

F2: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years